...
首页> 外文期刊>Human Molecular Genetics >BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypes
【24h】

BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypes

机译:BEST1蛋白质稳定性和降解途径在常染色体显性最佳疾病和常染色体隐性嗜好术中核算不同视网膜表型

获取原文
获取原文并翻译 | 示例
           

摘要

Mutations in bestrophin-1 (BEST1) are associated with distinct retinopathies, notably three forms with autosomal dominant inheritance and one condition with an autosomal recessive mode of transmission. The molecular mechanisms underlying their distinct retinal phenotypes are mostly unknown. Although heterozygous missense mutations in BEST1 reveal dominant-negative effects in patients with autosomal dominant Best disease (BD), heterozygous mutations associated with autosomal recessive bestrophinopathy (ARB) display no disease phenotype. Here we show that the recessive mutations trigger a strong and fast protein degradation process in the endoplasmic reticulum (ER), thereby favoring a decreased stoichiometry of mutant versus normal BEST1 subunits in the assembly of the homo-pentameric BEST1 chloride channel. In contrast, dominant mutations escape ER-associated degradation and are subjected to a slightly delayed post-ER degradation via the endo-lysosomal degradation pathway. As a result, increased formation of a non-functional BEST1 channel occurs due to a roughly equimolar incorporation of normal and mutant BEST1 subunits into the channel complex. Taken together, our data provide insight into the molecular pathways of dominantly and recessively acting BEST1 missense mutations suggesting that the site of subcellular protein quality control as well as the rate and degree of mutant protein degradation are ultimately responsible for the distinct retinal disease phenotypes in BD and ARB.
机译:Bestrophin-1(Best1)中的突变与不同的视网膜病变有关,特别是具有常染色体显性遗传的三种形式和具有常染色体隐性透射模式的一种条件。其不同视网膜表型的分子机制主要是未知的。虽然最好的杂合物畸变突变突出术患者常染色体占优势最佳疾病(BD)的患者,与常染色体隐性Bestrophyophaty(ARB)相关的杂合突变显示无疾病表型。在这里,我们表明隐性突变在内质网(ER)中引发了强烈和快速的蛋白质降解过程,从而有利于在均多五聚体最佳的氯化物通道组装中突变与正常最佳的突变体的化学计量。相反,显性突变逃逸ER相关的降解,经由内透溶血剂降解途径进行稍微延迟的ER后劣化。结果,由于正常和突变体Best1亚基的大致平衡掺入到通道络合物中,发生了非功能性最佳1通道的增加。我们的数据集中了解统治性和隐性的作用的分子途径,表明亚细胞蛋白质质量控​​制的部位以及突变蛋白质降解的速率和程度最终对BD中的不同视网膜疾病表型负责和arb。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号